P2.06-001 A Study of MGCD516, a Receptor Tyrosine Kinase (RTK) Inhibitor, in Molecularly Selected Patients with NSCLC or Other Advanced Solid Tumors
Werner, Theresa, Heist, Rebecca, Carvajal, Richard, Adkins, Douglas, Alva, Ajjai, Goel, Sanjay, Hong, David, Bazhenova, Lyudmila, Saleh, Mansoor, Siegel, Robert, Kyriakopoulos, Christos, Blakely, CollТом:
12
Мова:
english
Журнал:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2016.11.1494
Date:
January, 2017
Файл:
PDF, 179 KB
english, 2017
File converter
Більше результатів пошуку
More benefits 
